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Abstract 
Adipose tissue engineering offers a promising alternative to the current breast 
reconstruction options. Here we investigated patient-specific breast scaffolds 
fabricated from poly(D,L)-lactide polymer with pore sizes >1 mm for their potential in 
long-term sustained regeneration of high volume adipose tissue. An optimized 
scaffold geometry was modelled in silico via a laser scanning data set from a patient 
which underwent breast reconstruction surgery. After the design process scaffolds 
were fabricated using an additive manufacturing technology termed fused deposition 
modelling. Breast-shaped scaffolds were seeded with human umbilical cord 
perivascular cells and cultured under static conditions for 4 weeks and subsequently 
2 weeks in a biaxial rotating bioreactor. These in vitro engineered constructs were 
then seeded with human umbilical vein endothelial cells and implanted 
subcutaneously into athymic nude rats for 24 weeks. Angiogenesis and adipose 
tissue formation were observed throughout all constructs at all timepoints. The 
percentage of adipose tissue compared to overall tissue area increased from 37.17% 
to 62.30% between week 5 and week 15 (p<0.01), and increased to 81.2% at week 
24 (p<0.01), while the seeded endothelial cells self organised to form a functional 
capillary network. The presented approach of fabricating  customised scaffolds using 
3D scans represents a facile approach towards engineering clinically relevant 
volumes of adipose tissue for breast reconstruction. 
Keywords: 
Biofabrication, scaffolds, adipose tissue engineering, breast reconstruction, , 
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1.0 Introduction 
Breast cancer is a global problem and a major cause of morbidity, with an estimated 
number of 300,000 new cases diagnosed in 2013 [1]. While treatment concepts have 
moved from radical mastectomy to lumpectomy and adjuvant therapies such as 
chemotherapy, radiation or hormone therapy, there is still a significant number of 
patients suffering from the consequences of surgical removal of breast tissue.  Such 
procedures often have negative psychological effects on the well-being of the 
patients. Earlier studies by Renneker et al. [2] showed that mastectomy is directly 
related to a psychological syndrome “marked by anxiety, insomnia, depressive 
attitudes, occasional ideas of suicide, and  feelings of shame and worthlessness”  
[2].  Although several new approaches exist today in order to anatomically 
reconstruct the breast, some women still report the feeling of an altered body image 
[3]. This might partly be due to the fact that reconstructive methods available today 
repair, yet do not regenerate native adipose tissue, which is necessary for restoring 
the natural shape and feel of a breast. Prosthetic silicone-based implants are 
associated with a high occurrence of a mid and long-term foreign body response in 
form of a fibrous implant encapsulations altering the shape of the breast and more 
importantly leading to patient pain and discomfort  [4-6]. Autologous fat tissue 
transplantation and free tissue flap transfers are also often used by plastic surgeons. 
However are associated with a high risk of tissue shrinkage, fat necrosis and/or oil 
cyst formation [7, 8].  
To overcome the limitations of the current breast reconstructive techniques, impetus 
has been steadily growing towards cell-based regeneration of adipose tissue. Tissue 
Engineering and Regenerative Medicine (TE&RM) approaches aim to move the field 
away from methods to replace damaged tissue with permanent implants to more 
 4 
 
biological solutions that are able to restore structure and function of autologous 
tissue [9]. Since the publication of the pioneering research paper in year 1999 by 
Patrick et al. [10] who used preadipocyte-seeded polyglycolic acid (PLGA) scaffolds 
for regenerating small volumes of adipose tissue,  research groups from around the 
world [11-19] have achieved breakthroughs which moved the field forward. However, 
formation of sufficient volumes of mature adipose tissue remains a major problem  
and so far it has not been possible to maintain the structural entity of tissue 
engineered adipose constructs for more than 8-16 weeks [20, 21]. Current 
developmental efforts are therefore directed towards resolving problems that prevent 
the upscale of adipose tissue engineering concepts towards clinically relevant 
volumes that can be maintained throughout the life of the patient.  
The shape and size of the breast of each patient is different, hence the scaffold of 
each breast reconstruction should be customized [9, 22, 23]. Previous studies 
undertaken in our laboratory have established a clinically viable methodology to 
design scaffolds for breast tissue engineering applications from patient scan data 
sets [24]. In this project, our main focus was on the design and fabrication of 
anatomically-shaped and patient-specific scaffolds using a biopolymer that degrades 
over the time scale of 1-2 years. Previous reports have indicated that a scaffold 
made out of such a slow-degrading polymer provides a long-term stable platform for 
the adipose tissue to regenerate and to mature, remodel its environment and 
stabilise [25]. It is well known that not only large but fully interconnected pore 
architectures facilitate cell invasion and blood vessel ingrowth crucial for maintaining 
long-term viability of adipose tissue [26, 27]. Since the diameters of a great number 
of the larger rat blood vessels infiltrating into a tissue-engineered construct lie in the 
500-1500µm range [28], we hypothesized that a slow-degrading biopolymer with 
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pore sizes in the range 1000-2000 microns allows for efficient vascular in-growth and 
long-term sustained regeneration of high volume adipose tissue within a rat 
subcutaneous model.  
2.0 Methods and Materials 
2.1 Image acquisition and Computer Aided Design (CAD) model generation 
A 3D CAD file was generated based on a 3D laser scan performed on a 46 year old 
female patient who suffered from an invasive ductal carcinoma from a data set 
previously derived [24]. Briefly, a Vivid 910 dot-laser scanner with built-in high 
precision camera (Konica Minolta, Marinouchi, Japan) was used to perform a 3D 
scan of the patient from three angles (0o frontal, and -30o and +30o oblique anterior). 
The images were imported in Rapidform2006 (Inus Technology, Seoul, South Korea) 
and merged into a single-shell object [29]. A custom surfacing algorithm was 
generated to model a virtual chest wall which was merged with the breast surface 
shell to obtain a watertight model of the solid breast. This watertight model was then 
meshed and exported as a Standard-Tesselation-Language (STL) file.  
2.2 Design & Fabrication of scaffolds  
The volume of the original CAD model (194 cm3) was scaled down to 3 cm3. 
Skeinforge-55, open-source slicing software, was used to generate machining 
computer-numerical-control (CNC) code from the CAD file. Custom slicing software 
was designed to selectively remove the perimeter shells of each layer. The resultant 
CNC code was then used to fabricate the scaffolds using the Replicator 3D printer 
(Makerbot Industries, New York, USA). During extrusion of the scaffolds, the layer 
thickness was set to 0.37 mm, porosity value was set to 90%, operating flow rate 
and feed rate were matched to 41 mm/s and extrusion temperature was set to 
220oC. 
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2.3 MicroCT (µCT) evaluation of scaffolds 
The specimens were scanned on a Scanco µCT40 (Scanco AG, Brüttisellen, 
Switzerland) at 8 µm resolution, employing 55 kV and 145 µA with 250 ms exposure 
time. Porosity, pore-size and filament-size distributions were obtained by employing 
a modified trabecular bone histomorphometry algorithm.  
2.4 Isolation and culturing of primary human umbilical cord perivascular cells 
(HUCPVCs) 
HUCPVCs represent a rich source of human mesenchymal cells found in the 
perivascular region of the human umbilical cord [30] and have recently gained 
attention in the tissue engineering field due to their short doubling time, and high 
occurrence of colony-forming-unit-fibroblast (CFU-F). HUCPVCs isolated from 
consenting full-term caesarean section patients were obtained from Tissue 
Regeneration Therapeutics Inc. (Toronto, Canada). The HUCPVCs were isolated as 
reported previously [30] and were received in passage 2. HUCPVCs were 
maintained in Dulbecco’s Modified Eagle Medium (containing 4600 mg/L glucose) 
(Invitrogen, Carlsbad, USA) growth media supplemented with 10% (v/v) fetal bovine 
serum (Lonza, Basel, Switzerland) and 1% (v/v) Penicillin (10,000 U/ml) – 
Streptomycin (10,000 μg/ml) (Invitrogen, Carlsbad, USA) in a humidified incubator at 
37oC and 5% (v/v) CO2.  
2.5 Culturing of primary human umbilical vein endothelial cells (HUVECs) 
HUVECs were obtained from American Type Culture Collection (Rockville, MD, 
USA) and maintained in F12K medium (Invitrogen, Carlsbad, USA)  supplemented 
with 0.1 mg/ml heparin (Sigma, St Louis, USA), 0.05 mg/ml Endothelial Cell Growth 
Supplement (Millipore, Billerica, USA), 10% (v/v) fetal bovine serum  (Lonza) and 1% 
(v/v) and Penicillin (10,000 U/ml) – Streptomycin (10,000 μg/ml) (Invitrogen, 
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Carlsbad, USA), in a humidified incubator at 37oC and 5% (v/v) CO2. HUVECs were 
used between passages 2 and 8.  
2.6 Production of GFP Lentiviruses and transduction of HUVECs 
HUVECs were labelled with enhanced green fluorescent protein (eGFP) using a 
pLenti CMV GFP Puro (658-5) plasmid (Addgene 17448) and packaged with 
plasmids pRSV-Rev, pMDLg/pRRE and pMD2.G (contains VSV.G gene) (Addgene 
12253, 12251 and 12259). The pLenti CMV GFP Puro plasmid were amplified in 
Escherichia coli and purified using W/Endo-free Qiagen Maxi-Prep Kit (Promega) 
according to the manufacturer’s instructions and packaging plasmids were amplified 
in Escherichia coli and purified using Maxi-Prep Kits (Qiagen). Packing cell line 293T 
cells (GenHunter Corp.) in a T75 flask were transfected with 6.6 mg pLenti CMV 
GFP Puro (empty) and 3.3 mg of each packaging plasmids pRSVRev, pMDLgpRRE 
and pMD.G in 133 μl 1.25 M CaCl2, 0.5 ml H2O and 0.66 ml 2 x HEPES buffered 
saline and the cells were incubated at 37°C/ 5% CO2. Four hours later, the medium 
was removed, cells were washed twice with warm phosphate-buffered saline (PBS) 
and replaced with 5 mL of complete DMEM. The cell culture supernatant was 
harvested 48 hr later by centrifugation at 850 g for 7 min at 4°C, followed by filtration 
of the supernatant through a 0.45 μm filter. The viral supernatant was concentrated 
80-100 times using Amicon Ultra 15 ml centrifugal filter units (Millipore). The lentiviral 
stocks were stored in small aliquot at -80°C for titration and cell transfection. Titer of 
the concentrated lentivrial was determined by plating 4x105 293T cells in 6-well plate 
and infecting the cells with serial (10-fold) dilutions of concentrated lentivirus. After 
48 hours, cells were trypsinised, washed three times with cold PBS and fixed with 
1% paraformaldehyde (PFA) for 30 mins. The fixed cells were analyzed using 
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FACSCalibur for eGFP expression and for a typical preparation, the titer was 
approximately 107 to 108 infectious units per ml. GFP                                                                                                                                                                                                                                                                                                                                                                                                  
HUVECs (2x106) in T175 flask were infected with 10 infectious units per cell in 5 ml 
of complete DMEM with polybrene (8 μg/ml) (Santa Cruz biotechnology) for 1 hr 
incubation at 37°C/ 5% CO2 before the addition of 15 ml of complete 
DMEM/polybrene. Incubation was continued for 24 hrs before DMEM/polybrene 
media was replaced by complete DMEM. 48 hours post-transduction, the media was 
replaced with DMEM complete with 0.5 μg/mL of puromycin (Invitrogen), as 
determined previously by a puromycin kill curve (0.2-4 μg/mL) with HUVECs, in order 
to select for eGFP positive cells.   
2.7 Preparation of cell-seeded TECs 
Breast-shaped PDLLA scaffolds were first washed with sterile PBS and for 
sterilisation immersed in 70% ethanol overnight. Once the ethanol evaporated, the 
scaffolds were subjected to UV-irradiation for 30 minutes on each surface. Sterilised 
scaffolds were later placed in PBS overnight to pre-wet them. HUCPVC were 
detached using 0.25% trypsin, washed with PBS and resuspended in culture media. 
20x106 HUCPVC were seeded onto each scaffold within a fibrin matrix (Baxter, 
Toongabbie, Australia) to improve cell attachment. After trypsinisation, the cell 
suspension was diluted with thrombin solution at a ratio of 1:1. 600 µL of 
cell/thrombin suspension was mixed with 600 µL fibrinogen solution and seeded on 
each scaffold. Cell-seeded scaffolds were cultured at 37oC and 5% CO2 in complete 
DMEM.  
After 4 weeks of static culture, all scaffolds were subjected to a dynamic culture 
environment for 2 weeks utilising the TisXell biaxially rotating bioreactor (QuinXell 
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Technologies, Singapore) for 8 hours per day at 5 rpm. The bioreactor setup has 
been previously described elsewhere [31, 32].  
2.8 In vivo implantation into athymic nude rats 
The animal experiments were approved by the Animal Ethics Committee of the 
Queensland University of Technology (ethics approval number: 11-147). Three 7-
weeks old male athymic nude rats were purchased from the Animal Resources 
Centre (Perth/Australia). Rats were anaesthesized with a mixture of Ketamine (100 
mg/kg) and xylazine (10 mg/kg). Surgeries were performed in a laminar hood under 
sterile conditions. A single 3 cm midline incision was made over the spine of the rats. 
Subcutaneous pockets were created on both flanks by blunt dissection and one 
scaffold was placed in each pocket. Before the wound was closed, scaffolds were 
injected with a solution of HUVEC encapsulated in Matrigel (1.3 x 106 cells per 
scaffold). The wound was closed with clips and swabbed with sterile iodine. At the 
end of the surgery, analgesic (Buprenorphine at 0.05 mg/kg s.c.) was administered 
subcutaneously.  
2.9 Fluorescent imaging 
In vivo imaging to detect the GFP signal from HUVEC was performed on the IVIS 
Spectrum imaging system (Caliper Life Sciences, Alameda, California) every 3 
weeks. Rats were anaesthetized with 5% isoflurane and remaining fur was gently 
removed. Imaging was performed by setting the emission filter at 540 nm, excitation 
filter at 500 nm, exposure time at 0.2 seconds and luminescent exposure at 2 
seconds. The images were imported into IVIS Living Image (version 4.3.1) software 
(Caliper Life Sciences, San Jose, USA) and native tissue autofluorescence was 
subtracted using a spectral unmixing algorithm. Once the autofluorescence was 
subtracted, all images were normalised to a minimum colour scale of 800 counts. 
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2.10 Mechanical Testing 
Compression testing was performed on the explanted TECs using an Instron 5848 
microtester fitted with a 500 N load cell (Instron, Norwood, USA). Since the top and 
bottom surfaces of the breast scaffolds are convex in nature, a support and a loading 
mould (illustrated in Supplementary Fig 3) were fabricated in order to evenly 
distribute the forces on the TECs. The supporting structures were fabricated with 
Acrylonitrile butadiene styrene (ABS) polymer with a young’s modulus of 3.5 GPa. In 
order to minimise mechanical damage to the soft tissue, the testing protocol 
comprised a 2 mm compression of the scaffold at a rate of 0.6 mm/min.  
2.11 µCT Angiography 
Scaffolds (n=3) were used for µCT angiography. All animals were euthanized by CO2 
asphyxiation 6 months post implantation. Radiopaque contrast agent-enhanced µCT 
angiography was performed using a protocol adapted from Duvall et al. [33]. Briefly, 
a surgical catheter was inserted into the left ventricle of the heart and advanced into 
the ascending aorta. Isotonic saline was perfused into the vascular system using a 
peristaltic pump until the blood was washed out. Following this procedure, a 
polymerizable, lead chromate-based, radiopaque contrast agent (Microfil MV-122, 
Flow Tech, Carver, USA) prepared according to manufacturer’s instructions was 
perfused into the vascular system. Animal carcasses were stored at 4oC for 24 hours 
to allow polymerisation of the contrast agent. Scaffolds were then removed from the 
animals and stored in 4% PFA for 24 hours until µCT analysis.  
2.12 Histological and immunohistochemical analyses 
2.12.1 Hematoxylin & Eosin (H & E) 
 11 
 
Tissue was harvested from the rats after 5 and 15 weeks using a 5 mm biopsy punch 
penetrating through the entire height of the TECs (see Supplementary Fig 5). After 
explantation, TECs were fixed with 4% PFA, dehydrated and embedded in paraffin 
using a tissue processor (Excelsior ES, Thermo Scientific, Waltham, USA). 
Constructs were horizontally sliced to 5µm, deparaffinised with Xylene, rehydrated 
with a decreasing series of ethanol and stained with H & E. Stained slides were 
scanned with the SCN400 slide scanner (Leica, Solms, Germany) at 20x 
magnification. 
2.12.2 Immunohistochemical staining 
Endogenous peroxidase activity was blocked by incubating the slides with 3% H2O2 
at room temperature. Slides were washed three times with Tris-HCL (pH 7.4) for 2 
minutes and placed in tri-sodium citrate buffer for 20 min at 95 oC in a decloaking 
chamber. The slides were incubated with 2% bovine serum albumin (BSA) for 60 
minutes at room temperature and incubated with prediluted corresponding primary 
antibody overnight at 4oC. All the four primary antibodies used are listed in 
Supplementary Table 1. The slides were then incubated with immunoglobulin as 
secondary antibody as part of the DAKO Envision Dual Link System-HRP (Ref: 
K4061, Dako, Glostrup, Denmark) for 30-45 min at room temperature. The slides 
were washed 3 times with Tris-HCl and colour was developed by incubating the 
slides with 3,3'-Diaminobenzidine (DAB) solution (1:50) [DAKO liquid DAB+ 
substrate Chromagen System, Ref: K3468, Dako, Glostrup, Denmark]. Finally, the 
slides were washed once with Tris-HCl for 2 minutes and counter-stained with 
Haematoxylin for 2 minutes followed by 30 second immersion in 0.1% Ammonium 
Hydroxide.  
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2.13 Histomorphometry 
Histomorphometrical analyses were undertaken using two methods: a manual 
method and an automated approach. The manual method was undertaken using the 
Osteomeasure  histomorphometry analysis system (Osteometrics Inc., Decatur, GA, 
USA). All measurements were performed blinded on 4 consecutive sections from 
each scaffold at each time point. To determine the average adipose tissue area, the 
total area of the adipose tissue was first calculated (A). Secondly, the total area 
occupied by the scaffold struts was measured (S). Finally, the combined area of the 
tissue section was measured (C). The ratio of adipose tissue area to total tissue area 
(R) was calculated using the following formula: 
𝑅 =
𝐴
(𝐶 − 𝑆)
∗ 100% 
ImageJ (National Institutes of Health, MA, USA), in conjunction with Adipocyte Tools 
plugin developed by Montpellier RIO Imaging (Montpellier, France), was used for all 
automated calculations involving cell size distribution. The field of view (FOV) from 
each histological section was kept uniform at 4795 x 2282 µm. Background was first 
removed from each histological section by the pre-processing macro within the 
Adipocyte Tools plugin using the thresholding method. Minimum size of each cell 
was chosen to be 40 µm, maximum size as 800 µm and the number of dilates were 
set to be 10. The same threshold was also chosen to automatically set regions of 
interest (ROI) around the adipose cells. The automated method generated a small 
number of ROI artefacts. Artefacts that could be detected visually were manually 
removed. In order to remove the remaining artefacts, 10% of the smallest and 10% 
of the largest ROIs were excluded from any further analysis. Visualisation of both the 
manual as well as the automatic method can be found in Supplementary Fig 2. 
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Fibrotic capsules were identified from H & E stained histological sections as a dense 
layer of collagen fibres aligned parallel to the implant surface with a variable 
presence of fibroblasts and inflammatory cells [34]. 3 images chosen randomly from 
each scaffold were imported in ImageJ and measurement lines, approximately 50 
µm apart, were defined on the fibrotic capsule. Average thickness of the fibrotic 
capsule was derived from the average of such measurement lines.  
2.14 Statistical analysis 
All data are represented as mean ± SD and are subjected to one-way analyses of 
variance (one-way ANOVA) and Tukey’s post-hoc test (Sigmaplot 12.5). Significance 
levels were set at p< 0.05. All error bars represent standard deviation.  
3.0 Results 
3.1 Characterisation of scaffolds 
The gross morphology of the fabricated PDLLA scaffolds was highly similar to the 
CAD file obtained from the laser scanning of the breast region (Fig 1. a-c) and 
contained a regular array of interconnected pores. The axial pores of the scaffolds 
were larger than the transverse pores of the scaffolds. This observation was 
conﬁrmed by μCT measurements (Fig 1(e)), where the smaller pore sizes (200-400 
microns) reﬂected the transverse pores of the constructed scaffolds as seen in Fig 
1(d, right). The larger pore sizes (500-1000 microns) reﬂect the axial pores of the 
scaffolds as seen in Fig 1(d, left). The high porosity value of the scaffolds also 
implies more volume available for tissue/vascular ingrowth. From the 3D μCT 
reconstructed images it was also shown that the filament thicknesses across the 
entire scaffolds were largely homogeneous (Fig 1d).  
3.2 In vitro culture 
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To improve the seeding efficiency of cells onto the large volume scaffolds, a clinically 
approved hydrogel system, namely fibrin glue, was used. A fibrinogen/cell 
suspension was mixed with thrombin and immediately added to the scaffolds so that 
the fibrin clot was formed in situ within the scaffold pores. The scaffolds were also 
pre-wet in sterile PBS overnight prior to seeding them with cells. Initially, when the 
cells were encapsulated in fibrin glue, they showed a rounded morphology, however 
as shown in the light microscopy image in Supplementary Fig 1a, after 24 hours, 
filopodia began to develop. After day 28 days of static culture cells were seen to be 
bridging across the pores of the scaffold (Supplementary Fig 1b). The rotational 
motion of the TisXell bioreactor leading to increased perfusion of nutrients facilitated 
cell growth, as observed from the size and number of bridges across the pores, 
which increased significantly in 2 weeks under dynamic culture (Supplementary Fig 
1b, c).  
3.3 Fluorescent imaging 
Prior to the implantation of scaffolds into rats, the pre-cultured scaffold/cell 
constructs were further seeded with a suspension of GFP-labelled HUVECs in 
Matrigel in order to enhance the angiogenic potential of the TECs. The rats were 
subjected to in vivo fluorescence imaging every 3 weeks to detect the fluorescent 
signal from the implanted GFP-labelled HUVECs. The fluorescence signal could not 
be distinguished from the background noise on week 0. On week 2, the signal was 
localised at the right wing of the scaffold (Fig 2a). Over the next 15 weeks, the signal 
persisted at the initial location and seemed to invade towards the central regions of 
the scaffold (Fig 2 b-f).  
3.4 Scaffold explantation and degradation 
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No postoperative infections or macroscopic signs of foreign body reaction to the 
TECs occurred over the entire period of implantation. After 6 months of implantation, 
the TECs were retrieved for histological analysis. Upon visual examination, it was 
shown that the scaffolds were well integrated into the host body with no apparent 
major inflammatory reaction (Fig 3 a). Visual examination of the Microfil perfused 
samples revealed a widespread invasion of host vasculature into the engineered 
adipose tissue (Fig 3 b, c, d). MicroCT angiography of the scaffolds revealed a high 
degree of vascularisation equally distributed throughout the architecture (Fig 3c). 
Furthermore, it was also found that the scaffolds did show, as anticipated, significant 
degree in molecular weight loss (data not shown) (Fig 3 e). Our tissue engineering 
concepts [35] are based on the principle that the overall shape of the scaffold 
remained intact (Fig 3d). 
3.5 Formation of vascularised adipose tissue 
Hematoxylin & Eosin staining revealed formation of adipose tissue and blood vessels 
across all time points (Fig 4 a-h). H&E staining of tissue samples explanted at week 
5 (Fig 4 a & b) and 15 (Fig 4 c & d) showed a well vascularised adipose tissue 
construct. H&E staining of tissue samples explanted at week 24 demonstrated 
widespread regeneration of well-vascularised adipose tissue throughout the length, 
width and height of the scaffolds. No regions of necrosis, inflammation or cysts were 
observed. 
All constructs showed the formation of a thin fibrotic capsule around the constructs. 
Adipose cells could be identified microscopically by their typical ring-like morphology 
and a large vacuole in the middle of the cell. These characteristics enabled 
quantification of the area of fat tissue.  
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The percentage of adipose tissue compared to overall tissue area increased from 
37.17% to 62.30% between week 5 and week 15, and grew to 81.2% between week 
15 and week 24 (Fig 5a). The stiffness of the TECs decreased significantly from 3 
MPa to 1 MPa over 24 weeks of in vivo implantation (Fig 5b). The results from the 
fibrotic capsule thickness measurements are displayed in Fig 5c. The semi-
quantitative analysis of the thickness revealed that the size of the capsule increased 
from approximately 350 µm to 450 µm between week 5 and 15. However, as the 
scaffold degraded over time, the size of the capsule decreased to 200 µm as 
observed at week 24.  
Quantification of adipose cell area allowed the visualization of the distribution of 
different-sized cells as a histogram (Fig 5d). At week 5, the majority of the cells had 
a surface area between 200 and 500 µm with the histogram skewing towards the 
right and a small number of outliers.  At week 15, the number of cells counted 
increased considerably, but the histogram continued to remain skewed to the right 
with a higher number of outliers compared to those at week 5. The majority of cells 
had a surface area between 100 and 300 µm at week 15. The histogram at week 24 
was more balanced compared to week 5 and 15, however it had the highest spread 
of values, having a considerably higher number of cells with a surface area larger 
than 1000 µm. The cell count also increased significantly between week 5 and 15.  
Immunohistochemical staining for anti-human-mitochondria antibodies showed that a 
majority of the adipose tissue within the scaffold was of host origin, with human 
adipocytes aggregating into a small number of islands near the scaffold strands (Fig 
6 h , i). Staining for anti-GFP showed that a significant number of HUVECs self-
organised into a functional capillary network within the scaffold strands (Fig 6 e , f). A 
majority of the capillaries formed by HUVECs had a diameter less than 100 µm, were 
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clustered into domains approximately 800 µm x 400 µm in size and localised on the 
periphery of the TECs. All such capillaries also had presence of red blood cells, 
indicating their functional nature. Anti-CD68 staining showed that the scaffolds 
invoked an unspecific inflammatory response in close proximity to the scaffold 
strands (Fig 6 b , c). CD68-positive macrophages were not found more than 400 µm 
away from the nearest scaffold strand showing that unspecific immune reaction was 
not widespread and localised within a radius of approximately 400 µm of the scaffold 
strands.  
4.0 Discussion 
The overall goal of breast reconstruction after mastectomy is to restore the patient’s 
breast with functional tissue interfaces, and to maintain tactile sensation. The shape 
and size of the breast is different for each patient, hence the scaffold supporting the 
regeneration of the tissue interfaces needs to be customised. Here, the translation of 
scaffold-based tissue engineering applying the toolbox provided by Computer-Aided-
Design and Computer-Aided-Manufacturing (CAD/CAM) opens up new vistas for 
scaffold-based breast reconstruction. In this article, we present an integrated 
strategy where images are first taken of the breast region of a mastectomy patient 
using medical imaging techniques. The images captured can then be processed into 
a 3D computer-aided design (CAD) model which is then sent to a bioprinter to be 
fabricated into a highly porous biodegradable scaffold. The porosity and pore sizes 
can be tailored independently by changing the laydown pattern. The optimal porosity 
is always determined by a trade-off between mechanical properties and pore volume 
available for tissue ingrowth [36]. Stiffness and strength should be sufficient in the 
context of breast tissue engineering, as the scaffold should be sufficiently robust to 
not only resist changes in shape in vitro as a result of cell contraction forces yet also 
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the wound contraction forces which will be invoked during tissue regeneration. 
Furthermore, the breast region is also subjected to high biomechanical loads during 
sleeping and sports activities, and the TECs must be able to withstand those forces 
over a long period of time.  
Patrick et al. were among the first to study adipose tissue engineering in vivo [10]. 
Since then several research groups have developed different approaches to 
engineer fat tissue using different types of cells and/or scaffolds. Most of these 
studies used small volume scaffolds and implants (Supplementary Fig 4); therefore, 
there is a direct need of sustained regeneration of clinically relevant high-volume 
adipose tissue. Furthermore, very few studies have analysed the long-term 
behaviour of tissue engineered breast constructs to date. To our knowledge, we 
present the first such study utilising a large-volume patient-specific TEC in an in vivo 
model and achieving a sustained regeneration of adipose tissue up to 24 weeks.   
The volume of the originally designed scaffold (194 cm3) was scaled down for the 
rodent experiment to 3 cm3 (Table 3); yet it is important to note that it is a 
considerably larger volume than reported in most previous studies (for a comparison 
of volumes of scaffolds used for adipose tissue engineering, please see 
Supplementary Fig 4) was reconstructed. Furthermore, a 3 cm3 scaffold leads to a 
breast/body volume if 0.84% in a rodent, considerably larger than that of an average 
human female (0.63%). For a detailed comparison, see Supplementary Table 2.  
It is important to note here that, based on our tissue engineering philosophy[35, 37] 
we did not aim to produce a scaffold whose mechanical properties matched those of 
native adipose tissue. PDLLA has been also been used previously to engineer 
adipose tissue [38, 39]. PDLLA is a aliphatic polyester which characterized by bulk 
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degradation and has a modulus of 1.5 GPa [40, 41]. Our hypothesis was that the 
highly porous scaffold would maintain its shape and volume for at least 9-12 month 
without showing any signs of mass loss so that the regenerated tissue stably 
remodels several times in the highly porous scaffold architecture without being 
influenced by any degradation by products. 
As the scaffolds showed loss of molecular weight in both the in vitro and in vivo 
phase (data not shown), their mechanical properties also changed significantly over 
a period of 8 month (2 month in vitro and 6 month in vivo). Measurement of the 
Young’s modulus after explantation revealed that the TECs had 33% of the Young’s 
modulus compared to the orginal scaffold values; however, the form stability and 
integrity and form specificity remained unchanged, with the TEC recovering shape 
and volume completely after being subjected to 10% compression. The stiffness of 
the scaffold was measured at 3 MPa in comparison to the TEC which had a stiffness 
of 1 MPa post-implantation (Fig 5b) which is 2 orders of magnitude stiffer compared 
to native adipose tissue. As PDLLA  degradation occurs throughout the whole via 
bulk degradation the scaffold did lose its mechanical strength uniformly throughout 
its volume [42]. However, as per our hypothesis, the biodegradable scaffold was able 
to withstand the contraction forces for at least 6 months in vivo and did not show any 
mass loss or volume contraction.   
Scaffold architecture has a major impact on adipose tissue formation. Scaffolds 
morphologies formed by Fused Deposition Modelling (FDM) are homogeneously 
organised with precisely deposited struts and contain a highly interconnected 
channel network. Previous work within our group [43] and elsewhere [21] have 
shown that scaffolds containing small pores and pore interconnections are 
unsuitable for high volume adipose tissue regeneration. Diffusion of oxygen from the 
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surrounding tissues is sufficient only over a distance up to approximately 150 µm 
[44]. Therefore, in tissue constructs without adequate vascularization, autologous 
adipose tissue loses up to 60% of its volume post-transplantation because the cells 
in the centre of the graft are inadequately supplied with nutrients and transport of 
waste is not possible  [45, 46]. Pore sizes of 1.5 mm used in the presented study 
allowed vascular ingrowth into the scaffold during the early stages of the implantation 
which helped sustain the adipose volume for an extended period of time.  
Our results from anti-CD68 staining show the presence of macrophages, primarily 
bordering the scaffold strands which can be interpreted as an unspecific immune 
reaction. The invasion of these macrophages may have had a large role to play in 
the subsequent adipogenesis and vasculogenesis. Moldovan [47] and Anghelina et 
al. [48, 49] have shown that upon implantation, monocytes and macrophages first 
invade the extracellular matrix around the graft and form tunnels while clearing ECM 
along their path. Subsequently, endothelial cells and adipocytes are visualised in 
these macrophage-lined tunnels, indicating their development into functional 
capillary-like structures and vascularised adipose tissue. However, further 
investigations done by Debels et al. [50] have found no conclusive evidence of 
macrophages playing a direct role in neoadipogenesis and claim that the perceived 
neoadipogenesis is simply a result of increased angiogenesis, without further 
involvement of macrophages.  
Immunohistochemistry on paraffin embedded explants samples with human-specific 
mitochondria antibody confirmed the host derivation of the newly formed adipose 
tissue, indicating that the regeneration process is dependent on inductive factors 
embedded within Matrigel or excreted by the transplanted cells, rather than direct 
tissue formation by provided precursor cells. This finding complies with a study 
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performed by Stillaert et al. [51] who also used Matrigel in combination with FGF2 
and concluded that such an inductive graft causes the recruitment and differentiation 
of host-derived precursor cells into adipose cells. Previous studies [52, 53] have 
shown that adult adipose tissue houses a significant number of mesenchymal stem 
cells with pluripotential characteristics. There is a high likelihood that these cells 
were significantly involved in the neoadipogenesis process. Athymic nude rats are 
characterised by their lack of normal thymus and functionally mature T cells and are 
therefore useful in xenograft models [54]. However, they still possess allo- and xeno-
reactive natural killer cells that can recognise and kill major histocompatibility 
complex (MHC) incompatible cells through the recognition of both mismatches in the 
classical (RT 1.A) and non-classical (RT1.C/E) MHC class 1 regions. With increasing 
age, nude rats develop leukocytes, for example dendritic cells, T-like cells and T-cell 
receptors which may also contribute to specific innate immune responses [54]. At the 
time of implantation, it is reasonable to assume that the HUCPVC were mostly 
localised on the scaffold strands, which is also the region encapsulated by fibrous 
tissue and granulomatose reaction. It is therefore likely that the implanted HUCPVC 
were constantly triggering a response by the innate immune system of the host and 
did not survive long-term.  
As described previously, one of the goals of this research project was to construct a 
human vascular bed within a nude rat model. The aims of such a pursuit are not 
limited to tissue engineering applications where vasculogenesis by means of 
precursor cell induction can provide nutrition to adipose cells, but also to basic 
cancer research whereby humanised vascular structures can be used as a model to 
study the growth and proliferation of cancer metastases [55].  In situ fluorescent 
imaging showed that on week 2, the eGFP signal from the implanted HUVECs was 
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localised onto to the right wing of the scaffold. This observation was unexpected 
since the HUVECs were distributed homogeneously throughout the scaffold. One 
argument is that the movement of the rat and gravitational forces caused the cells to 
accumulate on the bottom region of the scaffold. Another possibility is that the 
HUVECs in the core regions of the scaffolds perished due to hypoxia, while those on 
the periphery survived owing to a greater nutrient exchange at these sites.  
Anti-GFP staining showed that in contrast to HUCPVC, GFP-labelled HUVECs 
survived the 6-month implantation process all throughout the scaffolds. However, 
their self-assembly into capillaries of diameters less than 100 µm was observed only 
around the periphery of the scaffold. The clustering of cells in the posterior regions of 
the scaffold may have led to increased cell-to-cell contact in these regions, which is 
a very important factor determining the extent of capillary network formation with a 
minimum critical density required for optimal capillary bed formation [56, 57]. 
Although further investigation is needed, the maintenance of such a humanised 
capillary bed in a nude rat model for 24 weeks in vivo opens up the possibility of 
generating vascular networks spanning a greater area for many tissue engineering 
approaches. 
6.0 Conclusion 
The development of a clinically translatable method of engineering breast adipose 
tissue requires investigation of several components. There must be coordination 
between all key aspects of the tissue engineering process, including the selection of 
cell source, scaffold design and material, cellular environment and means of surgical 
strategy, in order for the engineering of breast tissue to be successful. To our 
knowledge this is the first study showing a sustained regeneration of high volume 
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adipose tissue over a long period of time using a customized biodegradable scaffold 
designed by utilizing 3D laser imaging data sets acquired from a breast 
reconstruction patient.   
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Figure Captions: 
Fig 1. Scaffold fabrication and characterisation. (a) Illustration of laser scanning performed on a patient suffering 
from invasive ductal carcinoma.  (b) The data from the laser scan was used to generate a CAD model of the 
patient’s left breast. (c) The CAD model was used to generate porous patient-specific scaffolds (shrunk down to 
25% of their original size) showing high shape fidelity to the CAD model. (d) MicroCT scans of the fabricated 
scaffolds showed homogeneity of filament thickness across the entire volume of the scaffold. (e) Histogram of 
pore size measurements showing the distribution of pore sizes in the scaffolds. (f) Scaffolds fabricated with a 
highly reproducible porosity of 90 %. (g) SEM images showing the surface of the scaffold bars and struts. 
Fig 2. Fluorescence signal from the GFP-labelled HUVECs detected using an IVIS bioluminescence scanner. 
Due to rapid movements of the rats immediately after the implantation of the scaffold, the HUVECs injected in the 
scaffold pockets of all rats got dislocated and accumulated in the posterior region of the scaffold. The signal from 
viable HUVECs increased steadily from week 2 until week 17. 
Fig 3.  (a) Scaffolds explanted after 24 weeks showed good integration with the host tissue with no observable 
signs of inflammation and fibrotic encapsulation.  (b) Perfusing the animals with Microfil allowed the visualisation 
of all blood vessels within the scaffold and the surrounding tissue areas. The arrows in yellow show large blood 
vessels supplying oxygen and nutrients to the tissue within the scaffolds. (c) 3D image obtained from microCT 
reconstruction of the scaffolds explanted from Microfil-perfused animals showing a well-established network of 
capillaries throughout the entire volume of the scaffold. (d) Top view and (e)side view of fabricated scaffold (left) 
and explanted tissue engineered constructs (TECs) (right) after 24 weeks. The distribution of capillaries can be 
qualitatively visualised on the explanted TECs.  
Fig 4. (a, b, c, d) Hematoxylin and Eosin (H&E) staining of tissue samples explanted at week 5 (a,b) and 15 (c,d) 
show a well vascularised adipose tissue and no signs of major inflammation or cyst formation. (e, f, g, h) H&E 
staining of samples explanted at Week 24. The scaffolds were sectioned in two orientations: transverse (e, g) and 
longitudinal (f, h). Representative sections are shown. Widespread regeneration of well-vascularised adipose 
tissue was observed throughout the length, breadth and height of the scaffolds. No regions of necrosis, major 
inflammation or cysts were observed.  
Fig 5. (a) Box and whiskers plot showing the adipose tissue area relative to total tissue area over 24 weeks. 
Adipose tissue area increased significant (p<0.01) from approximately 40% on Week 5 to approximately 60% on 
Week 15 finally reaching almost 80% on week 24 (p<0.01). The variability across the samples was low, 
especially in the Week 24 tissue extracts. (b) Graph showing the compressive Young’s modulus of scaffold pre- 
and post-implantation. Mechanical properties of the scaffold decreased significantly (p<0.01) from 3MPa to 1MPa 
over 24 weeks in vivo implantation. The stiffness of native adipose tissue is represented by the red dashed line 
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[58] .  (c) Box and whiskers plot showing mean thicknesses of the fibrous capsule surrounding the scaffold. As 
the scaffold degraded the thickness of the capsule decreased significantly (p<0.01) from 400µm to 300 µm 
between weeks 5 and 15 and down to 200 µm in week 24. The variability in the samples was high on week 15.  
(d) Histogram showing the distribution of adipose cells according to the cell surface area. Generally, the number 
of adipose cells increased significantly from week 5 to 24. At week 5, a majority of the cells had a surface area 
between 200 and 500 µm2. On week 15, the cells generally shrunk in area, with the majority of cells having an 
area between 150 and 350 µm2. Finally on week 24, the cells once again expanded in area and the majority had 
surface area between 200 and 500 µm2.*** statistically significant, p< 0.01. 
Fig 6. Histological staining of scaffolds explanted on week 24. (a) Hematoxylin and Eosin (H & E) staining of 
scaffolds showing overall tissue morphology. (b & c) CD68 staining showing the presence of macrophages near 
the scaffold strands. Density of macrophages was low in areas away from the scaffold strands. (d) Anti-vWF 
staining for the blood vessels showing a well vascularised tissue. (e & f) Anti-GFP staining for the presence of 
GFP-labelled HUVECs showing the assembly of HUVECs into functional capillaries. (g) isotype control. (h & i) 
Staining for human mitochondria showing the host-origin of the regenerated tissue. Human fat cells (black arrow) 
were localised in small islands near the scaffold strands.  Scale bars = 100µm. 
Supplementary Tables: 
Supplementary Table 1. List of primary antibodies. 
Primary Antibodies Description 
Anti-Von Willebrand factor Polyclonal Rabbit Anti-Human Von Willebrand Factor: Ref A 0082 
(DAKO, Glostrup, Denmark) 
Anti-CD68 Monoclonal Mouse Anti Rat CD68: Ref MCA341GA (AbD Serotec, 
Oxfordshire, UK) 
Anti-GFP Rabbit Polyclonal Anti-GFP antibody: Ref AB290 (Abcam, Cambridge, 
UK) 
Anti-human mitochondria Mouse monoclonal anti-human mitochondria antibody: Ref AB92824 
(Abcam, Cambridge, UK) 
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Table 2. Comparison of breast/body volumes of humans and rodents. 
Type of Tissue Volume (cm3) Breast/Body Volume Ref 
Whole human body 66,400 
0.63% 
[59] 
Human breast volume 420 [60] 
Whole rat body 353 
0.84% 
[61] 
Breast scaffold volume 3  
 
Supplementary Figure Captions: 
Supplementary Fig 1. (a) Cell morphology on day 1 post seeding suspended in fibrin glue. Cells do not remain 
rounded and are seen to spread and connect with neighbouring cells. (b) 28 days post culture the cells begin to 
form wide bridges across the gaps of the scaffolds (dotted by yellow triangles). (c)  DAPI-Phalloidin staining of 
cells at 28 days post-culture to visualise cells forming a continuous sheet along the scaffold strands. Blue (DAPI): 
cell nuclei, Red (Phalloidin): cell actin filament.  
Supplementary Fig 2. (a-c) Images depicting the workflow of the automated algorithm to count the number of 
adipose cells on a histology section and also their cell surface areas. (d-f) Images depicting the workflow showing 
manual demarcation of adipose tissue areas using Osteomeasure software.  
Supplementary Fig 3. Schematic diagram of the test setup used for compression testing of scaffolds. Due to the 
curved nature of the scaffold surfaces, special top and bottom surface attachments following the contours of the 
scaffolds were produced. The top attachment links with the Instron microtester plunger providing uniform stress 
across the entire scaffold. The attachments were produced with non-porous acrylonitrile butadiene styrene (ABS) 
with a considerable higher stiffness compared to the 90% porous PDLLA scaffolds, to minimise their influence on 
the load readings.  
Supplementary Fig 4. Graph showing comparison of volumes of scaffolds used for adipose tissue engineering 
research. Volume of the scaffold used in the present study is dotted by a horizontal line showing that it is 
considerably higher than the volumes used in most other studies.  
Supplementary Fig 5. Illustration showing the position of the samples collected using biopsy punch outs at 
weeks 5 and 15. Areas shaded in dark purple represent tissue excised by the biopsy punch.  
